Scarica l'app Stockscreener
3.25
1.22%
-0.04
Dopo l'orario di chiusura:
3.20
-0.05
-1.54%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RLAY Giù?
Forum
Previsione
Precedente Chiudi:
$3.29
Aprire:
$3.31
Volume 24 ore:
2.47M
Relative Volume:
1.11
Capitalizzazione di mercato:
$545.56M
Reddito:
$25.55M
Utile/perdita netta:
$-341.97M
Rapporto P/E:
-1.1607
EPS:
-2.8
Flusso di cassa netto:
$-304.44M
1 W Prestazione:
+1.56%
1M Prestazione:
+30.52%
6M Prestazione:
-44.35%
1 anno Prestazione:
-54.10%
Intervallo 1D:
$3.17
$3.365
Intervallo di 1 settimana:
$2.96
$3.47
Portata 52W:
$1.775
$10.72
Relay Therapeutics Inc Stock (RLAY) Company Profile
Nome
Relay Therapeutics Inc
Settore
Industria
Telefono
617-370-8837
Indirizzo
399 BINNEY STREET, CAMBRIDGE
Confronta RLAY con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RLAY
Relay Therapeutics Inc
|
3.25 | 545.56M | 25.55M | -341.97M | -304.44M | -2.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
501.15 | 126.96B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
605.61 | 65.06B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
649.67 | 37.54B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
259.39 | 32.56B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
255.77 | 26.40B | 3.81B | -644.79M | -669.77M | -6.24 |
Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-17 | Iniziato | Wells Fargo | Equal Weight |
| 2024-09-10 | Ripresa | Goldman | Buy |
| 2024-09-10 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-09-10 | Downgrade | Oppenheimer | Outperform → Perform |
| 2024-05-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2023-04-20 | Aggiornamento | Jefferies | Underperform → Hold |
| 2023-04-19 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-04-13 | Iniziato | Raymond James | Outperform |
| 2023-02-03 | Iniziato | Oppenheimer | Outperform |
| 2022-09-30 | Iniziato | Barclays | Equal Weight |
| 2022-09-02 | Iniziato | Stifel | Buy |
| 2022-06-06 | Iniziato | Jefferies | Underperform |
| 2022-02-01 | Iniziato | Berenberg | Buy |
| 2021-07-21 | Iniziato | BofA Securities | Buy |
| 2020-12-15 | Reiterato | H.C. Wainwright | Buy |
| 2020-12-08 | Iniziato | JMP Securities | Mkt Outperform |
| 2020-11-05 | Iniziato | H.C. Wainwright | Buy |
| 2020-08-10 | Iniziato | Cowen | Outperform |
| 2020-08-10 | Iniziato | Goldman | Buy |
| 2020-08-10 | Iniziato | Guggenheim | Buy |
| 2020-08-10 | Iniziato | JP Morgan | Neutral |
Mostra tutto
Relay Therapeutics Inc Borsa (RLAY) Ultime notizie
There Is A Lot Of Upside Potential For Relay Therapeutics Inc(NASDAQ: RLAY) - Stocksregister
why Relay Therapeutics Inc [RLAY] is a Good Choice for Investors After New Price Target of $17.40 - dbtnews.com
LPL Financial LLC Sells 6,564 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Relay Therapeutics president sells $95,381 in stock By Investing.com - Investing.com South Africa
Relay Therapeutics chief legal officer sells $44,040 in stock By Investing.com - Investing.com South Africa
Relay Therapeutics CFO sells shares worth $44,246 By Investing.com - Investing.com South Africa
Relay Therapeutics Inc Stock: Executives Sell Shares Amid Mixed Signals - sharewise
Relay Therapeutics CFO sells shares worth $44,246 - Investing.com Australia
Relay Therapeutics chief legal officer sells $44,040 in stock - Investing.com
Relay Therapeutics president sells $95,381 in stock - Investing.com
Relay Therapeutics executive sells $36,540 in stock - Investing.com
Relay Therapeutics Executives Sell Shares to Cover Tax Obligations and Under Trading Plan - TradingView
Healthy Upside Potential: Relay Therapeutics Inc (RLAY) - Sete News
Trading Day Review: Relay Therapeutics Inc (RLAY) Loses Momentum, Closing at 3.10 - DWinneX
Relay Therapeutics Inc: Weathering Stock Market Storms with 528.51M Market Cap - investchronicle.com
Relay Therapeutics, Inc. (NASDAQ:RLAY) Shares Sold by Legal & General Group Plc - Defense World
RLAY (Relay Therapeutics Inc) may reap gains as insiders became active recently - knoxdaily.com
Relay Therapeutics Inc (RLAY) shows promising results - uspostnews.com
Relay Therapeutics to Announce First Quarter 2025 Financial Resu - GuruFocus
Relay Therapeutics to Announce First Quarter 2025 Financial Results and Corporate Highlights on May 5, 2025 - The Manila Times
Layoff Tracker: Ono Cuts 83 Employees in Massachusetts - BioSpace
Relay Therapeutics Q1 2025 Earnings: Precision Medicine Pioneer Reports Financial Results May 5 - Stock Titan
Russell Investments Group Ltd. Has $329,000 Stock Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Relay Therapeutics (RLAY) Expected to Announce Quarterly Earnings on Thursday - Defense World
Ready to Jump After Recent Trade: Relay Therapeutics Inc (RLAY) - Sete News
Keeping an Eye on Relay Therapeutics Inc (RLAY) After Insider Trading Activity - knoxdaily.com
Upward Trajectory: Relay Therapeutics Inc (RLAY) Posts a Gaine, Closing at 2.93 - DWinneX
Relay Therapeutics Inc (RLAY)’s highs and lows: A closer look at its stock price fluctuations - uspostnews.com
Small Cap Stock Relay Therapeutics Inc (RLAY) Is A Buy – Analysts - Marketing Sentinel
Relay Therapeutics, Inc. (NASDAQ:RLAY) Stock Position Lifted by Geode Capital Management LLC - Defense World
Relay Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Highlights - ADVFN
Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
Relay Therapeutics (RLAY): The Most Promising Penny Stock According to Analysts - Yahoo Finance
Franklin Resources Inc. Sells 1,338,037 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Wells Fargo & Company Begins Coverage on Relay Therapeutics (NASDAQ:RLAY) - Defense World
Wells Fargo Initiates Coverage of Relay Therapeutics (RLAY) with Equal-Weight Recommendation - Nasdaq
This Twin Disc Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
Wells Fargo Initiates Relay Therapeutics at Equalweight With $4 Price Target - marketscreener.com
Relay Therapeutics (RLAY) Assigned Equal Weight by Wells Fargo | - GuruFocus
Relay Therapeutics (RLAY) Assigned Equal Weight by Wells Fargo | RLAY Stock News - GuruFocus
Is Relay Therapeutics Inc. (NASDAQ:RLAY) the Best Biotech Penny Stock to Buy According to Hedge Funds? - Insider Monkey
Top Cancer Stocks to Buy to Boost Your Portfolio's Health - Yahoo Finance
Relay Therapeutics: Trying To Find That Right Price - Seeking Alpha
Corebridge Financial Inc. Acquires 7,314 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Vanguard Group Inc. Acquires 566,595 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Relay Therapeutics Inc (NASDAQ: RLAY): Blank Check On Growth? - stocksregister.com
KLP Kapitalforvaltning AS Purchases New Stake in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
American Century Companies Inc. Buys 51,499 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Relay Therapeutics, Inc. (RLAY): Among Stocks Under $10 that Will Triple - Insider Monkey
Relay Therapeutics Inc Azioni (RLAY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.47%
2.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):